Sihuan Pharmaceutical Holdings Group Ltd
Company Profile
Business description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Contact
Zhubang 2000
22nd Floor, Building 4
West Balizhuang, Chaoyang District
Beijing100025
CHNT: +86 1057693700
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
2,767
Stocks News & Analysis
stocks
BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs
stocks
Our view of ANZ’s strategic plan
stocks
Perplexing buyback from overvalued ASX share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,299.00 | 21.90 | 0.24% |
CAC 40 | 8,124.82 | 205.20 | 2.59% |
DAX 40 | 24,284.29 | 47.35 | 0.20% |
Dow JONES (US) | 46,270.46 | 202.88 | 0.44% |
FTSE 100 | 9,432.20 | 20.57 | -0.22% |
HKSE | 25,910.60 | 469.25 | 1.84% |
NASDAQ | 22,521.70 | 172.91 | -0.76% |
Nikkei 225 | 47,672.67 | 825.35 | 1.76% |
NZX 50 Index | 13,307.40 | 30.41 | 0.23% |
S&P 500 | 6,644.31 | 10.41 | -0.16% |
S&P/ASX 200 | 8,990.90 | 22.20 | 0.25% |
SSE Composite Index | 3,912.21 | 46.98 | 1.22% |